Today: 13 May 2026
Nvidia Stock Faces a $20 Billion AI Chip Test as Cerebras Heads for IPO

Nvidia Stock Faces a $20 Billion AI Chip Test as Cerebras Heads for IPO

SAN FRANCISCO, April 18, 2026, 08:33 PDT

Nvidia Corp’s dominance in AI chips faced a fresh market check on Friday, when Cerebras Systems—a direct rival in the AI processor space—unveiled plans for a U.S. IPO and filed for a Nasdaq debut with the ticker “CBRS.” Cerebras’ numbers for 2025 jumped out: revenue climbed to $510 million, up from $290.3 million, and the company flipped to a profit, posting $1.38 per share after last year’s $9.90-per-share loss, according to Reuters. Reuters

The timing’s key as competition intensifies over inference—the grunt work AI systems do to generate answers. Reuters, referencing a report from The Information, said OpenAI reached a deal to pay Cerebras upwards of $20 billion across three years for servers built on Cerebras chips. Reuters noted it hadn’t independently confirmed those details; OpenAI didn’t reply to questions, and Cerebras wouldn’t comment.

There’s a lot riding on this. FactSet’s John Butters said Friday Nvidia is projected to deliver the biggest boost to year-over-year earnings growth—both for the “Magnificent 7” tech cohort and the broader S&P 500 this quarter. Strip out NVIDIA, Butters noted, and that group’s expected earnings growth drops hard, sliding to 6.4% from 22.8%.

Nvidia finished Friday up 1.7% at $201.68, pushing its market cap to roughly $4.53 trillion at the most recent close. Advanced Micro Devices barely budged. Broadcom picked up nearly 2.0%, evidence investors were still wading into the AI-chip trade as the week wrapped up.

Cerebras still lags far behind Nvidia in scale. Nvidia’s revenue for the quarter ended Jan. 25 hit a record $68.1 billion, and the company is looking for $78.0 billion, give or take 2%, in the current fiscal first quarter. That forecast doesn’t count on any data-center compute revenue from China, according to the company.

Nvidia hasn’t limited itself to its core turf; hardware and software from the chipmaker are now reaching into new spaces. Earlier this week, Cadence Design Systems and Nvidia announced a tie-up on AI for robotics. Nvidia CEO Jensen Huang, speaking at a Cadence event in Santa Clara, put it plainly: “We’re working with you across the board on robotic systems.” Reuters

There’s no one-size-fits-all among Nvidia’s rivals. Cerebras pushes a highly specialized AI system. AMD, for its part, has landed major chip supply agreements with buyers eager to branch out. Broadcom, meanwhile, works with tech giants to craft custom processors—an answer for those balking at Nvidia’s higher price tags.

There’s risk on both sides here. Cerebras needs to convince IPO investors that demand tied to OpenAI can actually translate into a bigger, lasting business. Nvidia, on the other hand, runs up against the slower-moving risk that cloud and AI buyers might start moving some inference jobs elsewhere—chasing speed, lower prices, or simply more leverage. Nvidia would keep its lead, but the next phase wouldn’t be on autopilot.

Nvidia’s fiscal Q1 2027 results land May 20. On the line: proof that appetite for Blackwell and the rest of its data-center lineup isn’t slipping, even as rival hardware crops up in IPO filings, custom-chip pacts, and those cloud procurement negotiations getting more crowded.

Stock Market Today

  • Recent 13F Filings Reveal Walmart Holdings Trends with Havemeyer Exit
    May 13, 2026, 3:07 PM EDT. Analysis of the latest 13F filings for Q1 2026 shows Walmart Inc (WMT) held by 51 out of 87 funds. 13F filings disclose long stock positions, excluding short bets, so the full investment stance may be obscured. Notably, Havemeyer Place exited its Walmart holdings. Most funds made modest changes: some increased shares, others trimmed. Franklin Resources significantly reduced WMT shares, cutting over 9 million. Capital World Investors and JPMorgan Chase notably increased positions, adding millions of shares. This mixed activity suggests diverse investor strategies despite broad confidence in Walmart's market presence. Close monitoring of these shifts offers insight into hedge funds' varying outlooks on Walmart's prospects.

Latest articles

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

13 May 2026
Palantir shares fell 4.4% to $129.97 Wednesday as CEO Alex Karp met President Volodymyr Zelenskiy in Kyiv to discuss expanding AI use in Ukraine’s war effort. Kyiv’s Brave1 Dataroom project, launched with Palantir, is training AI models to intercept Russian drones. Russia fired at least 800 drones at Ukraine on Wednesday, killing six. Palantir’s U.S. government and commercial revenue surged in the first quarter.
Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

13 May 2026
Grab shares fell 1.1% to $3.60 in New York after first-quarter revenue beat estimates, rising 24% to $955 million. Profit jumped to $120 million from $10 million a year earlier. Investors weighed strong results against Indonesia’s new 8% ride-hailing commission cap. Grab kept its 2026 revenue and adjusted EBITDA outlook unchanged.
SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

13 May 2026
SoFi acquired PrimaryBid’s technology to expand IPO access for retail investors, confirmed by both companies. SoFi shares fell 2.9% to $15.44 after Truist cut its price target, citing concerns over loan and technology platforms. The acquisition follows a drop in technology-platform accounts and comes as SoFi reported strong first-quarter revenue and member growth. Terms of the deal were not disclosed.

Popular

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 18.04.2026

Netflix Stock Sinks After Weak Forecast as Reed Hastings Exit Raises Growth Questions
Next Story

Netflix Stock Sinks After Weak Forecast as Reed Hastings Exit Raises Growth Questions

Go toTop